Insights

Strong Funding Position Summit Therapeutics secured substantial funding of $235 million in September 2024, enhancing its capacity to expand its clinical portfolio and accelerate the development of innovative therapies, presenting opportunities for partners in late-stage biopharmaceutical development.

Expanding Clinical Trials With ongoing late-stage trials for ivonescimab targeting non-small cell lung cancer and potential expansion into breast cancer, there is a significant opportunity to collaborate with Summit on pivotal clinical trial services, regulatory support, and commercialization partnerships.

Leadership Growth The recent appointment of a Chief Commercial Officer signifies a strategic focus on scaling commercial capabilities, making it an ideal time for sales teams to engage with Summit on market access solutions, sales enablement, and healthcare provider engagement strategies.

Innovative Product Pipeline Summit’s focus on developing first-in-class bispecific antibodies like ivonescimab shows a commitment to cutting-edge biotech solutions, offering avenues for partnership in research collaborations, bioservices, and distribution opportunities for novel therapeutics.

Industry Engagement Active participation in high-profile industry events and conferences like WCLC 2025 and J.P. Morgan Healthcare Conference presents multiple touchpoints for outreach and relationship-building with Summit’s leadership and stakeholders to explore strategic collaborations.

Summit Therapeutics, Inc. Tech Stack

Summit Therapeutics, Inc. uses 8 technology products and services including FloQast, Power BI, Open Graph, and more. Explore Summit Therapeutics, Inc.'s tech stack below.

  • FloQast
    Accounting And Finance
  • Power BI
    Business Intelligence
  • Open Graph
    Content Management System
  • PFS
    E-commerce Platforms
  • Workiva
    Governance, Risk And Compliance
  • IQVIA
    Health Platform
  • ADP
    Human Resource Management System
  • PHP
    Programming Languages

Media & News

Summit Therapeutics, Inc.'s Email Address Formats

Summit Therapeutics, Inc. uses at least 2 format(s):
Summit Therapeutics, Inc. Email FormatsExamplePercentage
First.Last@summitplc.comJohn.Doe@summitplc.com
92%
F-Last@summitplc.comJ-Doe@summitplc.com
4%
First.Middle@summitplc.comJohn.Michael@summitplc.com
3%
Last@summitplc.comDoe@summitplc.com
1%
FLast@smmttx.comJDoe@smmttx.com
50%
First.Last@smmttx.comJohn.Doe@smmttx.com
33%
First.Last@smmttx.comJohn.Doe@smmttx.com
17%

Frequently Asked Questions

Where is Summit Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Summit Therapeutics, Inc.'s main headquarters is located at 601 Brickell Key Drive, Suite 1000. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Summit Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Summit Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Summit Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Summit Therapeutics, Inc.'s official website is smmttx.com and has social profiles on LinkedIn.

What is Summit Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Summit Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Summit Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, Summit Therapeutics, Inc. has approximately 285 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: G. E.Chief Operating Officer And Board Member: M. S.Chief Commercial Officer (cco): R. L.. Explore Summit Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Summit Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Summit Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Summit Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Summit Therapeutics, Inc.'s tech stack includes FloQastPower BIOpen GraphPFSWorkivaIQVIAADPPHP.

What is Summit Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Summit Therapeutics, Inc.'s email format typically follows the pattern of First.Last@summitplc.com. Find more Summit Therapeutics, Inc. email formats with LeadIQ.

When was Summit Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Summit Therapeutics, Inc. was founded in 2003.

Summit Therapeutics, Inc.

Biotechnology ResearchFlorida, United States201-500 Employees

Summit Mission Statement:

To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when appropriate.

We accomplish this by building a team of world class professional scientists and business administrators that apply their experience and knowledge to this mission. Team Summit exists to pose, strategize, and execute a path forward in medicinal therapeutic health care that places Summit in a well-deserved, top market share, leadership position. Team Summit assumes full responsibility for stimulating continuous expansion of knowledge, ability, capability, and well-being for all involved stakeholders and highly-valued shareholders.

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Miami, Florida, and we have additional offices in Menlo Park, California, and Oxford, UK.

Section iconCompany Overview

Headquarters
601 Brickell Key Drive, Suite 1000
Phone number
Website
smmttx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2003
Employees
201-500

Section iconFunding & Financials

  • $100M$250M

    Summit Therapeutics, Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Summit Therapeutics, Inc.'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.